PharmaCircle

PharmaCircle provides pharmaceutical professionals with the tools to find, analyze and drill down on information that can uncover new opportunities.

[EIN Presswire: Press Releases @EINPresswirePR]

Ceiba Heathcare Expands into Germany https://t.co/jGnulN8zfF

[PharmaCircle @pharmacirclellc]

@pharmacirclellc at @IAmBiotech
https://t.co/vYUeUw2aa6

[EIN Presswire: Press Releases @EINPresswirePR]

PharmaCircle Launches Smart Search Trial Version https://t.co/rx8cHaKt3A

[EIN Presswire: Press Releases @EINPresswirePR]

PharmaCircle Smart Search Engine https://t.co/FfDcUIcvwt

[PharmaCircle @pharmacirclellc]

Smart Search Engine is one search box with unlimited possibilities to create queries: https://t.co/9npukIU2zv
#smarttsearchengine #pharmacircle #pharmaceutical #biologics # drug delivery #formulation

[PharmaCircle @pharmacirclellc]

With COVID-19 slowly winding down PharmaCircle will be attending select conferences to share our latest product developments. Want a PharmaCircle refresher? Visit PharmaCircle https://t.co/y7uAP7fOnw  to schedule a demo #pharmacircle #smartsearchengine

[PharmaCircle @pharmacirclellc]

Join PharmaCircle in Boston October 17/18 #PODD2018

[PharmaCircle @pharmacirclellc]

2018Q1 EMA Approvals Summary Report

PharmaCircle has compiled a summary report of the first quarter 2018 EMA Drug Approvals, which is available to read at https://t.co/5UHmuovBAo

The summary report was prepared using the PharmaCircle Pipeline & Products Intelligence database.

[PharmaCircle @pharmacirclellc]

FDA - First Quarter 2018 NDA and BLA Approvals

PharmaCircle has compiled the US FDA NDA & BLA approvals for Q1 2018 into a short report, which is available at https://t.co/Z7OCJBInbS.

The report was generated using the PharmaCircle Pipeline & Products Intelligence Database.

[PharmaCircle @pharmacirclellc]

Intellipharmaceutics submits NDA for Rexista® (oxycodone hydrochloride extended release). Is this the next generation abuse deterrent?

[PharmaCircle @pharmacirclellc]

Coherus BioSciences Files 351(k) for Biosimilar Pegfilgrastim

[PharmaCircle @pharmacirclellc]

Medtronic Receives FDA Approval For First Closed Loop "Artificial Pancreas"

[PharmaCircle @pharmacirclellc]

Bayer and DelSiTech Expand Novel Drug Delivery Technology Development to Ophthamics

[PharmaCircle @pharmacirclellc]

Amgen Makes Investment in RNAi Therapy With Arrowhead

[PharmaCircle @pharmacirclellc]

Amgen First Biosimilar Adalimumab Approved by FDA

[PharmaCircle @pharmacirclellc]

Insulet Enrolls First Patients in Clinical Trial for its Omnipod® Artificial Pancreas System

[PharmaCircle @pharmacirclellc]

Nanologica Enters Into Collaboration/Feasibility Agreements With GSK and Teva For Its NLAB Silica Particle Drug Delivery Technology

[PharmaCircle @pharmacirclellc]

#Pfizer Joins Abuse Resistant Opioid Market With Approval of Troxyca ER

[PharmaCircle @pharmacirclellc]

Heron Therapeutics Receives FDA Approval for #Sustol Extended Release Injectable Utilizing Biochronomer Technology

[PharmaCircle @pharmacirclellc]

#Abbvie Gains FDA Approval for #VIEKIRA XR, a Fixed Dose Combination Product for Hep C Containing Active Ingredients of VIEKIRA PAK